Applied BioCode Free Cash Flow Generation Index

Latest as of September 2022: -0.89x

Applied BioCode free cash flow generation index. Applied BioCode (6598) has a Free Cash Flow Generation Index of -0.89x as of September 2022. Free cash flow of NT$-5.65 Million represents -1% of operating cash flow (NT$6.35 Million).

FCF Generation Index

-0.89x
Free Cash Flow / Operating CF

Free Cash Flow

NT$-5.65 Million
TWD

Operating Cash Flow

NT$6.35 Million
TWD

Capital Expenditures

NT$12.00 Million
TWD

Free Cash Flow Generation Index of Applied BioCode (2022–2022)

Free cash flow generation index of Applied BioCode from 2022 to 2022. Historical FCF Generation Index trend for Applied BioCode across 1 annual periods. See Applied BioCode (6598) flexibility index to measure the company's free cash flow as a share of total liabilities.

Applied BioCode Free Cash Flow Generation Index by Year (2022–2022)

Applied BioCode free cash flow generation index by year from 2022 to 2022. Year-by-year Free Cash Flow Generation Index for Applied BioCode. For the full cash flow conversion analysis, see cash flow conversion of Applied BioCode.

Year FCG Index Free Cash Flow (TWD) Operating CF Capital Expenditures YoY Change
2022 0.85x NT$123.73 Million NT$145.87 Million NT$22.14 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).